OpenURL Connection Search

Select item for more details and to access through your institution.

Retrospective Comparison of mFOLFOXIRI With XELOX/SOX as Neoadjuvant Chemotherapy for Locally Advanced Rectal Cancer.
Published in:
In Vivo, 2021, v. 35, n. 2, p. 977, doi. 10.21873/invivo.12340
By:
- HIROYUKI KOADAMA;
- TETSUJI TERAZAWA;
- YASUNOBU ISHIZUKA;
- HIROKI YUKAMI;
- MASAHIKO AOKI;
- TAKAHIRO MIYAMOTO;
- TOSHIFUMI YAMAGUCHI;
- FUTUKARO SHIMAMOTO;
- TAKAYUKI KII;
- MASAHIRO GOTO;
- HIROKI HAMAMOTO;
- WATARU OSUMI;
- MASASHI YAMAMOTO;
- KEITARO TANAKA;
- JYUNJI OKUDA;
- KAZUHISA UCHIYAMA;
- KAZUHIDE HIGUCHI
Publication type:
Article
Impact of modified FOLFOX‐6 for patients with gastric cancer and a gastrointestinal obstruction.
Published in:
Asia Pacific Journal of Clinical Oncology, 2019, v. 15, n. 5, p. e91, doi. 10.1111/ajco.13110
By:
- Yukami, Hiroki;
- Terazawa, Tetsuji;
- Goto, Masahiro;
- Aoki, Masahiko;
- Asaishi, Ken;
- Yamaguchi, Toshifumi;
- Kuwakado, Shin;
- Kii, Takayuki;
- Higuchi, Kazuhide
Publication type:
Article
Phase I dose-escalation study on irinotecan, cisplatin, and S-1 combination in chemotherapy-naïve patients with HER2-negative advanced gastric cancer (HERBIS-4B, OGSG 1106).
Published in:
International Journal of Clinical Oncology, 2023, v. 28, n. 9, p. 1176, doi. 10.1007/s10147-023-02376-0
By:
- Yukami, Hiroki;
- Kawakami, Hisato;
- Yamaguchi, Toshifumi;
- Sakai, Daisuke;
- Shimokawa, Toshio;
- Kurokawa, Yukinori;
- Goto, Masahiro;
- Satoh, Taroh
Publication type:
Article
Primary tumor location as a predictor of survival in patients with RAS wild-type colorectal cancer who receive molecularly targeted drugs as first-line therapy: a multicenter real-world observational study by the Japanese Society for Cancer of the Colon and Rectum
Published in:
International Journal of Clinical Oncology, 2022, v. 27, n. 9, p. 1450, doi. 10.1007/s10147-022-02208-7
By:
- Ito, Takahiko;
- Takashima, Atsuo;
- Yamazaki, Kentaro;
- Yukami, Hiroki;
- Uetake, Hiroyuki;
- Tsuda, Masahiro;
- Suto, Takeshi;
- Moriwaki, Toshikazu;
- Sugimoto, Naotoshi;
- Ojima, Hitoshi;
- Takii, Yasumasa;
- Yasui, Hisateru;
- Esaki, Taito;
- Tsuji, Akihito;
- Goto, Masahiro;
- Saruta, Masayuki;
- Otsu, Satoshi;
- Shinozaki, Katsunori;
- Fujiwara, Toshiyoshi;
- Tamura, Takao
Publication type:
Article
Definitive chemoradiotherapy has comparable survival outcomes to esophagectomy in patients with clinical T1N0M0 esophageal squamous cell carcinoma: real-world data.
Published in:
International Journal of Clinical Oncology, 2022, v. 27, n. 8, p. 1279, doi. 10.1007/s10147-022-02185-x
By:
- Sawada, Kentaro;
- Kotani, Daisuke;
- Yukami, Hiroki;
- Mishima, Saori;
- Fujiwara, Hisashi;
- Kadota, Tomohiro;
- Nakajo, Keiichiro;
- Yoda, Yusuke;
- Nakamura, Masaki;
- Hojo, Hidehiro;
- Yano, Tomonori;
- Fujita, Takeo;
- Kojima, Takashi
Publication type:
Article
DENEB: Development of new criteria for curability after local excision of pathological T1 colorectal cancer using liquid biopsy.
Published in:
Cancer Science, 2022, v. 113, n. 4, p. 1531, doi. 10.1111/cas.15226
By:
- Miyo, Masaaki;
- Kato, Takeshi;
- Nakamura, Yoshiaki;
- Taniguchi, Hiroya;
- Takahashi, Yusuke;
- Ishii, Masayuki;
- Okita, Kenji;
- Ando, Koji;
- Yukami, Hiroki;
- Mishima, Saori;
- Yamazaki, Kentaro;
- Kotaka, Masahito;
- Watanabe, Jun;
- Oba, Koji;
- Aleshin, Alexey;
- Billings, Paul R.;
- Rabinowitz, Matthew;
- Kotani, Daisuke;
- Oki, Eiji;
- Takemasa, Ichiro
Publication type:
Article
CIRCULATE‐Japan: Circulating tumor DNA–guided adaptive platform trials to refine adjuvant therapy for colorectal cancer.
Published in:
Cancer Science, 2021, v. 112, n. 7, p. 2915, doi. 10.1111/cas.14926
By:
- Taniguchi, Hiroya;
- Nakamura, Yoshiaki;
- Kotani, Daisuke;
- Yukami, Hiroki;
- Mishima, Saori;
- Sawada, Kentaro;
- Shirasu, Hiromichi;
- Ebi, Hiromichi;
- Yamanaka, Takeharu;
- Aleshin, Alexey;
- Billings, Paul R.;
- Rabinowitz, Matthew;
- Oki, Eiji;
- Takemasa, Ichiro;
- Kato, Takeshi;
- Mori, Masaki;
- Yoshino, Takayuki
Publication type:
Article

Found: 7

Retrospective Comparison of mFOLFOXIRI With XELOX/SOX as Neoadjuvant Chemotherapy for Locally Advanced Rectal Cancer.

Impact of modified FOLFOX‐6 for patients with gastric cancer and a gastrointestinal obstruction.

Phase I dose-escalation study on irinotecan, cisplatin, and S-1 combination in chemotherapy-naïve patients with HER2-negative advanced gastric cancer (HERBIS-4B, OGSG 1106).

Primary tumor location as a predictor of survival in patients with RAS wild-type colorectal cancer who receive molecularly targeted drugs as first-line therapy: a multicenter real-world observational study by the Japanese Society for Cancer of the Colon and Rectum

Definitive chemoradiotherapy has comparable survival outcomes to esophagectomy in patients with clinical T1N0M0 esophageal squamous cell carcinoma: real-world data.

DENEB: Development of new criteria for curability after local excision of pathological T1 colorectal cancer using liquid biopsy.

CIRCULATE‐Japan: Circulating tumor DNA–guided adaptive platform trials to refine adjuvant therapy for colorectal cancer.